[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-592287-105":59,"doc-detail-592287-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hpv-vaccine-acceptance-in-a-clinic-based-sample-of-women-in-the-rural-south-research-article","HPV Vaccine Acceptance in a Clinic-based Sample of Women in the Rural South - Research Article","","Study evaluates HPV vaccine acceptability among underserved women in a rural southeastern U.S. region with high cervical cancer rates, aiming to inform future health education interventions. A clinic-based sample (18-64, ASCUS or higher and HPV DNA tested) completed a telephone interview with a 78% response rate. Among those who had heard of HPV, 81% were very likely to get vaccinated and 72% would vaccinate daughters; key desired information and cost as the main barrier are highlighted.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hpv-vaccine-acceptance-in-a-clinic-based-sample-of-women-in-the-rural-south-research-article/592287/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hpv-vaccine-acceptance-in-a-clinic-based-sample-of-women-in-the-rural-south-research-article/592287.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-10-15",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of the HPV vaccine acceptability study?","Question",{"text":112,"@type":113},"The study examined HPV vaccine acceptability among underserved women in a rural southeastern U.S. region to support future educational interventions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What were the main findings about vaccine willingness?",{"text":117,"@type":113},"Among participants who had heard of HPV, 81% were very likely to get the vaccine, and 72% would have their daughter vaccinated.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factor was identified as the main barrier to vaccination?",{"text":121,"@type":113},"Cost was identified as the main barrier to obtaining the HPV vaccine.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},592287,1792210217,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Research Article  \nHPV Vaccine Acceptance in a Clinic-based Sample of women in the Rural South  \nHeather M. Brandt, Patricia A. Sharpe, Donna H. McCree, Marcie S. Wright, Jennifer Davis, and Brent E. Hutto  \nABSTRACT  \nBackground: Human papillomavirus (HPV) is a very common sexually transmitted infection linked to cervical disease. Vaccines for some types of HPV were in development at the time of the study. Purpose: The study examined HPV vaccine acceptability among underserved women in a rural region of the southeastern U.S. with high rates of cervical cancer for development of future educational interventions. Methods: A clinic-based sample of women (aged 18-64; ASCUS or higher and tested for HPV DNA) completed a telephone interview (response rate = 78%). Results: Among participants who had ever heard of HPV (n=108), 81% were “very likely” to get the vaccine and 72% would have their daughter vaccinated. These participants desired information about vaccine safety (100%), efficacy (100%), side effects (100%), clinician recommendation (96%), cost (94%), and composition of the vaccine (94%). Cost was identified as the main barrier (55%). Among a subset of participants who reported HPV positivity (n=49), younger age, being single, and high HPV knowledge level were associated with specific types of desired information before getting the HPV vaccine. Discussion: Similar to previously reported vaccine acceptability studies, acceptance among participants in this rural region of the south was also high. Participants also desired more information about the vaccine. Translation to Health Education Practice: Public health educational efforts must address health education issues related to vaccine acceptability and increase HPV knowledge and understanding.  \nBrandt HM, Sharpe PA, McCree DH, Wright MS, Davis J, Hutto BE. HPV vaccine acceptance in a clinic-based sample of women in the rural south. Am J Health Educ. 2009;40(3):174-180. This paper was submitted to the Journal on June 15, 2008, revised and accepted for publication on December 26, 2008.  \nBACKGROUND  \nGenital human papillomavirus (HPV) infection is a very common sexually transmitted infection (STI) in the United States (US) .1 Persistent high-risk HPV infection is necessary, but not sufficient to cause the most common types of invasive cervical cancer.2-6 Most genital HPV infections are transient and are resolved by a healthy immune system within nine months to a year.7 However, the financial and psychosocial burden associated with cervical dysplasia and cervical cancer as a result of genital HPV infection is high.8, 9  \nTwo HPV vaccines (Cervarix™ by GlaxoSmithKline, Rixensart, belgium and Gardasil® by Merck & Company, Rahway,  \nHeather M. Brandt is assistant professor in the Arnold School of Public Health, University of South Carolina, 800 Sumter St. HESC, Columbia, SC 29208; E-mail: [hbrandt@sc.edu. Patricia A](hbrandt@sc.edu. Patricia A). Sharpe is a research professor atthe Arnold School of Public Health Prevention Research Center, University of South Carolina, Columbia, SC 29208. Donna H. McCree, is a team leader atthe National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention,  \nNJ, United States) have undergone testing.10 Results show the HPV vaccines to be highly efficacious in preventing short-term mark-  \nAtlanta, GA 30333.MarcieS. Wright is a graduate research assistant at the Cancer Prevention and Control Program, University of South Carolina, Columbia, SC 29208.Jennifer Davis is a graduate research assistant at the Cancer Prevention and Control Program, University of South Carolina, Columbia, SC 29208. Brent E. Hutto is a research associate at the Arnold School of Public Health Prevention Research Center, University of South Carolina, Columbia, SC 29208.  \n Heather M. Brandt, Patricia A. Sharpe, Donna H. McCree, Marcie S. Wright, Jennifer Davis, and Brent E. Hutto   \ners of cervical disease and genital warts.10-15 Merck & Company, I","cbCaieHQD46pFwam","https://ap.wps.com/l/cbCaieHQD46pFwam","pdf",125150,"English","# Abstract\n## Background\n## Purpose and Methods\n## Results and Discussion\n## Translation to Health Education Practice","[{\"question\":\"What was the purpose of the HPV vaccine acceptability study?\",\"answer\":\"The study examined HPV vaccine acceptability among underserved women in a rural southeastern U.S. region to support future educational interventions.\"},{\"question\":\"What were the main findings about vaccine willingness?\",\"answer\":\"Among participants who had heard of HPV, 81% were very likely to get the vaccine, and 72% would have their daughter vaccinated.\"},{\"question\":\"Which factor was identified as the main barrier to vaccination?\",\"answer\":\"Cost was identified as the main barrier to obtaining the HPV vaccine.\"}]","HPV Vaccine Acceptance in a Clinic-based Sample of Women in the Rural South - Research Article | PDF",1792074247,18]